Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Contact Taylor H. Schreiber

From: Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy

Contact corresponding author